AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2019
Jan 10, 2019
34931_dirs_2019-01-10_e298c73d-a65f-4e9b-97ea-f3537789098f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CALADRIUS BIOSCIENCES, INC. (CLBS)
CIK: 0000320017
Period of Report: 2019-01-08
Reporting Person: LOSORDO DOUGLAS W (See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-01-08 | Common Stock | F | 1795 | $4.64 | Disposed | 97753 | Direct |
Footnotes
F1: Includes 39,438 shares of unvested restricted stock.